跳至主要内容
临床试验/CTRI/2025/04/085001
CTRI/2025/04/085001尚未招募2/3 期

A Randomized Controlled Trial to Assess the Efficacy of Siravedha and Distal Sodium Channel Block in the Management of Grudhrasi w.s.r Sciatica

National Institute of Ayurveda1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2025年4月30日最近更新:

试验速览

阶段
2/3 期
状态
尚未招募
入组人数
40
试验地点
1
主要终点
•Change in VAS, MRSS Score , SLR &Buckling test.

研究概览

简要总结

In Ayurveda Grudhrasi is a type of Vatvyadhi characterized by the clinical features of radiating pain from Spikha (gluteal region) to Pada (foot). Vata and Kapha are predominantly involved dosha in this disease and pain is the cardinal symptom.[i] Based on the symptomatology of Ghrudhrasi it can be corelated with the disease Sciatica in modern parlance.Sciatica occurs due to spinal nerve irritation and is characterized by pain in distribution of sciatica nerve manifesting into chronic radiating low back pain to lower limbs

Distal Sodium Channel Block (DSCB) is a newer concept of pain management which is now being widely practiced. Infiltration of local anesthetic drugs singly or in combination with those that augment or prolong its action around the nerve sheaths, at the most terminal branch along its course

Primary Objective:

•      To assess & compare the efficacy of Siravedha and DSCB in the management of Sciatica.

Secondary Objectives:

•       To assess the outcome of Siravedha and DSCB.

•       To assess the patient’s quality of life .(SF-12 Questionnaire)

Patients attending the OPD/IPD of the PG Department of Shalya Tantra, NIA hospital will be selected who will be fulfilling the criteria of inclusion, details of the study will be explained, and informed written consent of each patient will be taken on prescribed proforma. After that clinical trial will be executed

Total 40 patients will be selected after detail examination and divided in 2 groups of 20 patients each as per study protocol. All Procedures will be executed done under aseptic condition.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
25.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Age: Patients of either gender between 25-60 years.
  • Patient having typical clinical feature pertaining to the Sciatica like Constant aching pain felt in the lumbar region and may radiate to the buttock, thigh, calf and foot.
  • Diagnosed case of Sciatica through Positive Passive SLRT and Buckling test .
  • Patients having normal CT, BT and Hb above 10gm percent will undergo Siravedha Patient willing to undergo trial.

排除标准

  • •Patients with infectious diseases of spine.
  • •Patient with infection at the site of DSCB infiltration and Siravedha.
  • •Patients with past history of or ongoing malignancy or chemotherapy or radiotherapy •Patients with uncontrolled Diabetes mellitus, Cardiovascular diseases, HIV,Hypertension •Pregnant or Lactating Females.
  • •Patients with known hypersensitivity.

结局指标

主要结局

•Change in VAS, MRSS Score , SLR &Buckling test.

时间窗: BASELINE And 57 Days

•Improvement in symptoms of Sciatica.

时间窗: BASELINE And 57 Days

次要结局

  • Change in the quality of life of the patient.( as per SF-12 Questionnaire).(BASELINE And 57 Days)

研究者

申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验